Increasing prevalence of clostridium related disease and growing global geriatric population is expected to serve as a highimapct rendering deriver for the growth of clostridium diagnostics market over the forecast period. Furthermore, changing lifestyle, growing healthcare infrastructure, technological advancement such as artificial intelligence, alinia and automation is expected to boost market growth over the forecast period. Aforementioned, factors helps in the diagnosis and treatment of clostridium disease. With changing lifestyle people are becoming prone towards the disease, due to which clostridium bacteria are becoming more resistant towards the medicines.
Clostridium diagnostics market is segmented on the basis of technology, types and end-use. On the basis of technology, the market is bifurcated into, diagnostic tests and emerging diagnostic technologies. Further diagnostic tests are classified as counterimmunoelectrophoresis, fluorescent-antibody assays and poloymerase chain reactions. Counterimmunoelectrophoresis is one of the most commonly used diagnostic procedure to detect the nature of the bacteria and how they are functioning. Emerging diagnostic technologies are further classified as, monoclonal antibodies, DNA probes, differential light scattering, immunoassays, artificial intelligence, microcomputers & automation, flow cytometry, liposomes, MRI, chromatography, and gel microdroplets. Among these DNA probes which are also known as DNA hybridization held the largest market share as of 2013. This process is used to detect DNA sequence, type of protein, and gene of the DNA. Key factors attributing to its large share includes that this process is cost effective, rapid and simpler.
Clostridium difficle, clostridium botulinium, clostridium tetani, clostridium sordellii and clostridium perfringens are the types of clostridium diagnostics analyzed in the scope of study. Among these clostridium difficle held the majority of market in 2013. Key factors for its large share includes, increased usage of anti-biotics, which increases the chances of getting infected towards this disease. On the basis of end-use market is segmented into, commercial/private labs, hospitals, public health labs, and physician offices. Commercial/private labs emerged as most lucrative end use market and are expected to grow rapidly over the forecast period. Extensive use and availability of clostridium diagnostics devices in the labs has served as the high impact rendering driver for this segment.
Geographically, the clostridium diagnostics market is studied with respect to North America, Europe, Asia Pacific and RoW. North America and Europe are major centers for clostridium diagnostics owing to the presence of technologically updated systems, high expenditure in cardiac research & development programs, increased government funding, and high patient awareness levels. The growing economies in Asia Pacific such as India and China are expected to witness lucrative growth during the forecast period owing to the rising healthcare expenditure, and growing prevalence of clostridium.
Key players operating in clostridium diagnostics market includes Beckman Coulter Inc., Abbott Laboratories, Johnson & Johnson Services Inc., Biochem Pharmaceutical Industries Ltd., Siemens Healthcare, F. Hoffmann-La Roche Ltd and Olympus Corporation.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.